{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:42:20Z","timestamp":1785796940721,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.semarthrit.2025.152695","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T01:44:48Z","timestamp":1740275088000},"page":"152695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Validation of the polymyalgia rheumatica-activity score: A prospective cohort study"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-4801","authenticated-orcid":false,"given":"Lien","family":"Moreel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Doumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Betrains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Langhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blockmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vanderschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152695_bib0001","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0002","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0004","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/ard.2003.011379","article-title":"A disease activity score for polymyalgia rheumatica","volume":"63","author":"Leeb","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0005","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.22771","article-title":"The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission","volume":"57","author":"Leeb","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.23338","article-title":"Performance of the polymyalgia rheumatica activity score for diagnosing disease flares","volume":"59","author":"Binard","year":"2008","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0007","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3899\/jrheum.110866","article-title":"Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice","volume":"39","author":"Cleuziou","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0008","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.2022.15459","article-title":"Effect of Tocilizumab on disease activity in patients with active Polymyalgia rheumatica receiving glucocorticoid therapy: A randomized clinical trial","volume":"328","author":"Devauchelle-Pensec","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0009","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1016\/S2665-9913(23)00246-1","article-title":"Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial","volume":"5","author":"Saraux","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0010","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2665-9913(23)00032-2","article-title":"1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial","volume":"5","author":"Bolhuis","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"24","key":"10.1016\/j.semarthrit.2025.152695_bib0011","article-title":"Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"S2665-9913","author":"Saraux","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0012","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard-2022-223562","article-title":"Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: A phase 2 study","volume":"82","author":"Zhang","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0013","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00011-019-01293-1","article-title":"Potent repression of C-reactive protein (CRP) expression by the JAK1\/2 inhibitor ruxolitinib in inflammatory human hepatocytes","volume":"69","author":"Febvre-James","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/rheumatology\/kex477","article-title":"Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable","volume":"57","author":"Devauchelle-Pensec","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2023-003741","article-title":"Concordance and agreement between different activity scores in polymyalgia rheumatica","volume":"10","author":"D'Agostino","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0017","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pec.2014.12.013","article-title":"Patient Education and Counseling \u2018\u201c I suddenly felt I \u201d d aged \u2019\u2019: A qualitative study of patient experiences of polymyalgia rheumatica (PMR)","volume":"98","author":"Twohig","year":"2015","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0126758","article-title":"An impediment to living life\": why and how should we measure stiffness in polymyalgia rheumatica?","volume":"10","author":"Mackie","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0019","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3899\/jrheum.200248","article-title":"Outcomes measured in polymyalgia rheumatica and measurement properties of instruments considered for the OMERACT core outcome set: A systematic review","volume":"48","author":"Twohig","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3899\/jrheum.110977","article-title":"Patient-reported outcomes in polymyalgia rheumatica","volume":"39","author":"Matteson","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2023.152239","article-title":"Test-retest reliability of pain VAS\/NRS, stiffness VAS\/NRS, HAQ-DI and mHAQ in polymyalgia rheumatica: an OMERACT study","volume":"62","author":"Leung","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0022","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.22630","article-title":"Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: A study of 243 scenarios","volume":"57","author":"Binard","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2025.152695_bib0023","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3899\/jrheum.161109","article-title":"The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica","volume":"44","author":"Mackie","year":"2017","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T01:48:12Z","timestamp":1767750492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":23,"alternative-id":["S0049017225000666"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152695","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the polymyalgia rheumatica-activity score: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152695"}}